Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.27B |
| 2 |
Zimmer Biomet
ZBH
|
+$3.42B |
| 3 |
TransUnion
TRU
|
+$1.8B |
| 4 |
Qualcomm
QCOM
|
+$587M |
| 5 |
Alibaba
BABA
|
+$434M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$1.06B |
| 2 |
Pfizer
PFE
|
+$895M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$631M |
| 4 |
RTX Corp
RTX
|
+$546M |
| 5 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$516M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 8.41% |
| 2 | Healthcare | 8.04% |
| 3 | Technology | 7.66% |
| 4 | Energy | 6.94% |
| 5 | Consumer Discretionary | 6.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2626
iShares MSCI ACWI ex US ETF
ACWX
$11.5B
| $7.04M | ﹤0.01% |
159,319
+23,480
| +17% | +$1.09M |
|
2627
SPX Corp
SPXC
$11.5B
| $7.03M | ﹤0.01% |
385,890
+147,134
| +62% | +$2.87M |
|
2628
National Fuel Gas
NFG
$7.8B
| $7.03M | ﹤0.01% |
119,429
+29,034
| +32% | +$1.83M |
|
2629
CALL
ProShares Ultra QQQ
QLD
$12.6B
| $7.03M | ﹤0.01% |
1,537,600
+1,118,400
| +267% | +$5.27M |
|
|
MRO
2630
CALL
DELISTED
Marathon Oil Corporation
MRO
| $7.03M | ﹤0.01% |
264,900
+36,200
| +16% | +$1.02M |
|
2631
Sensient Technologies
SXT
$5.23B
| $7.02M | ﹤0.01% |
102,723
+29,131
| +40% | +$1.98M |
|
|
INFO
2632
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $7.01M | ﹤0.01% |
274,045
-1,505,699
| -85% | -$39.7M |
|
2633
Ironwood Pharmaceuticals
IRWD
$680M
| $7M | ﹤0.01% |
692,994
+263,033
| +61% | +$3.06M |
|
|
XLNX
2634
CALL
DELISTED
Xilinx Inc
XLNX
| $6.99M | ﹤0.01% |
158,300
-147,300
| -48% | -$6.64M |
|
2635
CRH
CRH
$63.8B
| $6.98M | ﹤0.01% |
248,336
+16,380
| +7% | +$461K |
|
2636
PUT
Sony
SONY
$136B
| $6.98M | ﹤0.01% |
1,229,000
-71,000
| -5% | -$435K |
|
2637
Logitech
LOGI
$14.6B
| $6.97M | ﹤0.01% |
475,128
-1,073,481
| -69% | -$16.1M |
|
2638
PUT
Truist Financial
TFC
$63.6B
| $6.97M | ﹤0.01% |
172,800
+36,700
| +27% | +$1.45M |
|
2639
PUT
Ulta Beauty
ULTA
$21.8B
| $6.97M | ﹤0.01% |
45,100
-2,100
| -4% | -$323K |
|
|
ACG
2640
DELISTED
AllianceBernstein Income Fund Inc
ACG
| $6.96M | ﹤0.01% |
935,553
+43,780
| +5% | +$336K |
|
2641
PUT
Estee Lauder
EL
$30.5B
| $6.92M | ﹤0.01% |
79,900
-27,600
| -26% | -$2.38M |
|
2642
PUT
Synaptics
SYNA
$4.26B
| $6.92M | ﹤0.01% |
79,800
+57,400
| +256% | +$5.24M |
|
|
ATHN
2643
PUT
DELISTED
Athenahealth, Inc.
ATHN
| $6.92M | ﹤0.01% |
60,400
+200
| +0.3% | +$23.9K |
|
2644
Brown & Brown
BRO
$23.7B
| $6.88M | ﹤0.01% |
418,740
-103,862
| -20% | -$1.7M |
|
|
MDRX
2645
CALL
DELISTED
Veradigm Inc. Common Stock
MDRX
| $6.87M | ﹤0.01% |
502,500
+501,400
| +45,582% | +$6.77M |
|
2646
CALL
Wheaton Precious Metals
WPM
$50B
| $6.87M | ﹤0.01% |
396,300
+50,300
| +15% | +$967K |
|
2647
Vanguard Information Technology ETF
VGT
$138B
| $6.87M | ﹤0.01% |
517,240
+126,392
| +32% | +$1.72M |
|
|
DBD
2648
DELISTED
Diebold Nixdorf Incorporated
DBD
| $6.86M | ﹤0.01% |
195,876
-195,308
| -50% | -$6.89M |
|
2649
Helen of Troy
HELE
$648M
| $6.85M | ﹤0.01% |
70,257
-20,938
| -23% | -$1.84M |
|
|
TARO
2650
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $6.83M | ﹤0.01% |
47,506
-12,790
| -21% | -$1.82M |
|
Similar funds
Goldman Sachs's Q2 2015 Portfolio in Review
As of Q2 2015, Goldman Sachs held 7,731 positions worth $323B, up 3.7% from $311B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Goldman Sachs deployed $13.1B of net new capital in Q2 2015, opening 673 new positions and adding to 3,224 existing holdings. Its largest new stake was TransUnion: 72,355,340 shares worth $1.82B.
By sector, the portfolio is most concentrated in Financials at 8.4% of assets, up from 8% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Gilead Sciences, an estimated $1.06B trimmed.
- Goldman Sachs's largest Q2 2015 buy was TransUnion: 72,355,340 shares worth $1.82B.
- Goldman Sachs added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $4.27B increase.
- Goldman Sachs's biggest Q2 2015 reduction was Gilead Sciences, cutting an estimated $1.06B.
- Goldman Sachs fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $386M.
- Goldman Sachs's ten largest holdings make up 14% of its $323B portfolio in Q2 2015.
- Goldman Sachs opened 673 new positions and closed 497 in Q2 2015.
- Goldman Sachs's portfolio value rose 3.7% quarter-over-quarter to $323B.
Based on Goldman Sachs's 13F filing for Q2 2015, filed 14 Aug 2015.